| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |